Cite
Parenti G, Zuppaldi A, Gabriela Pittis M, et al. Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease. Mol Ther. 2016;15(3):508-514doi: 10.1038/sj.mt.6300074.
Parenti, G., Zuppaldi, A., Gabriela Pittis, M., Rosaria Tuzzi, M., Annunziata, I., Meroni, G., Porto, C., Donaudy, F., Rossi, B., Rossi, M., Filocamo, M., Donati, A., Bembi, B., Ballabio, A., & Andria, G. (2007). Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease. Molecular therapy : the journal of the American Society of Gene Therapy, 15(3), 508-514. https://doi.org/10.1038/sj.mt.6300074
Parenti, Giancarlo, et al. "Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease." Molecular therapy : the journal of the American Society of Gene Therapy vol. 15,3 (2007): 508-514. doi: https://doi.org/10.1038/sj.mt.6300074
Parenti G, Zuppaldi A, Gabriela Pittis M, Rosaria Tuzzi M, Annunziata I, Meroni G, Porto C, Donaudy F, Rossi B, Rossi M, Filocamo M, Donati A, Bembi B, Ballabio A, Andria G. Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease. Mol Ther. 2007 Mar;15(3):508-514. doi: 10.1038/sj.mt.6300074. Epub 2016 Dec 08. PMID: 28182897.
Copy
Download .nbib